Lisanti Capital Growth’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,560	Closed	-$851K	–	141
2020 Q4	$851K	Buy	+5,560	New	+$851K	0.12%	124
2020 Q2	–	Sell	-16,690	Closed	-$708K	–	122
2020 Q1	$708K	Buy	16,690 +7,175	+75%	+$304K	0.23%	98
2019 Q4	$580K	Buy	+9,515	New	+$580K	0.15%	110